Contineum (CTNM) Q2 R&D Jumps 78%
Contineum Therapeutics, Inc. Class A Common Stock · PHARMACEUTICAL PREPARATIONS · Now $13.49
+8.6% in 3d after detection
Post-detection moves
1h
—
1d
+4.9%
3d
+8.6%
7d
+5.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS